In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
Head and Neck Surgeon Benjamin Roman seen talking with MSK colleagues.
A Second Opinion Can Reduce Cancer Costs and Improve Care

Learn how a second opinion at a highly specialized cancer center such as MSK can lead to treatment that costs less and improves quality of life and survival.
Gail Goode
How MSK Is Increasing Diversity in Cancer Clinical Trials to Improve Treatments

An MSK clinical trial is helping Gail Goode overcome multiple myeloma and sheds new light on how cancer affects people of diverse ethnic backgrounds.
Joey Laurore and Dr. Bob Li
Feature
For Some People with Cancer, a Simple Blood Test Can Be a Lifesaver

He was given a wrong diagnosis. A blood test changed his life.
author finds help for chemo brain
Feature
Is Chemo Brain Real?

Cancer treatments like chemotherapy may cause cognitive changes, which experts call “chemo brain.” Learn how Memorial Sloan Kettering experts help patients with this condition.
Binglong Zhang at work in the lab
Top Cancer Research Advances at MSK in 2025

MSK researchers continued to make strides against cancer in 2025. Learn about some of their top discoveries.
Dr. Alexander Drilon
FDA Grants Accelerated Approval to Repotrectinib for Cancers with NTRK Fusions 

The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.
Rosario Costas-Muñiz is a psycho-oncologist focused on the needs of the Latino community.
For Latino People With Cancer, Mental Health A Focus For MSK Psycho-Oncologist

Rosario Costas-Muñiz’s work is helping Latino patients at MSK and across Latin America.
Pictured: Timothy Chan
In the Lab
Investigators Sequence the Genome of a Rare Head and Neck Cancer

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Dr. Piro Lito
In the Lab
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers in the Lab

MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.
MSK surgeon José Guillem and patient Elliot Katz
In the Clinic
A Family Discovers an Unexpected Cancer Risk in Their Genes

Two brothers discuss their surprise at being diagnosed with Lynch syndrome.